Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.
about
Branched-chain amino acids for people with hepatic encephalopathyBranched-chain amino acids for people with hepatic encephalopathyBranched-chain amino acids in metabolic signalling and insulin resistanceAn association between dietary habits and traffic accidents in patients with chronic liver disease: A data-mining analysis.Prognostic significance of nonprotein respiratory quotient in patients with liver cirrhosis.The gut microbiome and the brain.Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosisPathophysiology and management of hepatic encephalopathy 2014 update: Ammonia toxicity and hyponatremia.New insights into the role of the branched-chain aminotransferase proteins in the human brain.Branched-chain amino acids for people with hepatic encephalopathy.Sarcopenia predicts minimal hepatic encephalopathy in patients with liver cirrhosis.Liver BCATm transgenic mouse model reveals the important role of the liver in maintaining BCAA homeostasis.Effect of different treatments and alcohol addiction on gut microbiota in minimal hepatic encephalopathy patients.A Comprehensive Review of Bioelectrical Impedance Analysis and Other Methods in the Assessment of Nutritional Status in Patients with Liver Cirrhosis.Effect of branched-chain amino acid supplementation on insulin resistance and quality of life in chronic hepatitis C patients.Associations between Zinc Deficiency and Metabolic Abnormalities in Patients with Chronic Liver Disease.Updating the neuropsychological test system in Japan for the elderly and in a modern touch screen tablet society by resetting the cut-off values.
P2860
Q24187134-9EE9B304-9A31-4F0B-A5C1-105C5FFCB0A0Q24187960-2AE61CFF-8E29-4175-8F5E-9C10CC0A19E3Q28249276-EA877118-83AD-4825-9111-0949C1B00CBEQ31086510-45D11E2B-8D78-4914-974B-91562A55F1C0Q34549563-C6C29A26-EA3C-4FD0-9529-0AEF920D6769Q34652493-31AC2866-F8FB-4745-A49D-46008CC1AC7EQ35637935-B3AD2638-FCA7-46B1-9463-936F9D09EB07Q38325703-5D4282C1-6ECB-489F-B28B-17C82A0269BDQ38339439-1CFE328B-6E0F-4A02-A767-82C9A47D9E69Q38778053-CBAEA3A7-C540-49A0-A561-909F36075DDCQ40443991-B369DFD5-D016-4022-9BEF-3DC63D6E8FC5Q45047747-141C89FF-B08E-4218-8AAF-F93E86DFD8C4Q47117570-BA59DE69-7713-46E2-8029-1A6583D90CC4Q48090027-15075345-F64B-4C51-BA83-6749267DDA35Q48513490-BA7CB8B9-616D-4E52-A45E-315AF9002BDAQ49232850-3B78FBF5-CAA7-454A-A072-29BE0C4B42B9Q50962753-8ED42DE8-8BB6-4B51-9AA3-59F6B5EAF18B
P2860
Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Effects of oral branched-chain ...... patients with liver cirrhosis.
@en
type
label
Effects of oral branched-chain ...... patients with liver cirrhosis.
@en
prefLabel
Effects of oral branched-chain ...... patients with liver cirrhosis.
@en
P2093
P2860
P356
P1476
Effects of oral branched-chain ...... patients with liver cirrhosis.
@en
P2093
Eitaro Taniguchi
Michio Sata
Takumi Kawaguchi
P2860
P304
P356
10.1177/0884533613496432
P577
2013-08-14T00:00:00Z